| |
Patients <18 years |
Patients ≥ 18 years |
Total patients |
| Total number of patients, N |
797 |
964 |
1,761 |
| Median age (range), years |
11.0 (4-17) |
35.0 (18-79) |
20.0 (4-79) |
| Gender, N (%) |
|
|
|
| Males |
490 (61.5) |
462 (47.9) |
952 (54.1) |
| Females |
307 (38.5) |
502 (52.1) |
809 (45.9) |
| Moderate to severe nasal symptoms, N (%) |
700 (87.8) |
872 (90.5) |
1,572 (89.3) |
| Moderate to severe eye symptoms, N (%) |
585 (73.4) |
699 (72.5) |
1,284 (72.9) |
| Asthma, N (%) |
282 (35.4) |
289 (30.0) |
571 (32.4) |
| First treated with SIT, N (%) |
638 (80.1) |
708 (73.4) |
1,346 (76.4) |
| Symptomatic medication in previous GPS, N (%) |
640 (80.4) |
719 (74.7) |
1,359 (77.3) |
| Dissatisfied with effect of symptomatic medication in previous GPS*, N (%) |
313 (49.4) |
430 (60.2) |
743 (55.0) |
*GPS: Grass Pollen Season |
